Education
About Us
Working with TipRanks
Follow Us
Thiogenesis Therapeutics Corp (TSE:TTI)
:TTI
| Dec 23 | Dec 22 | Feb 22 | Feb 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | - | - | - | - | - |
| Operating Income | $ -5.21M | $ -4.02M | $ -224.68K | $ -92.65K | $ -473.39K |
| EBITDA | $ -5.06M | $ -3.92M | $ -224.43K | $ -92.65K | $ -473.55K |
| Net Income | $ -5.06M | $ -3.92M | $ -224.46K | $ -92.68K | $ -476.30K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 7.24M | $ 6.29M | $ 3.43M | $ 146.43K | $ 41.13K |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 250.95K |
| Net Debt | $ -7.08M | $ -6.20M | $ -3.41M | $ -146.43K | $ 235.88K |
| Total Liabilities | $ 1.71M | $ 307.15K | $ 3.49M | $ 63.08K | $ 281.53K |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ -3.25M | $ -2.09M | $ -67.08K | $ -35.88K | $ -373.04K |
| Operating Cash Flow | $ -3.25M | $ -2.09M | $ -67.08K | $ -35.88K | $ -373.04K |
| Investing Cash Flow | |||||
| Financing Cash Flow |
Thiogenesis Therapeutics Corp Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.